Clinical Research Directory

Inclusion Criteria: * Aged ≥18 years * Male at birth * Identify as a woman/transgender woman * Should not be consistently using PrEP (less than four doses per week) * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program * Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write) * Have a smart phone that can take pictures Exclusion Criteria: * Unwilling to adhere to study procedures * Participation in an HIV vaccine trial * Have a life-threatening SUD\* * Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP * Unable to provide consent